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CXCR4 identifies transitional bone marrow premonocytes
that replenish the mature monocyte pool for peripheral
responses
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It is well established that Ly6Chi monocytes develop from common monocyte progenitors (cMoPs) and reside in the bone marrow (BM)
until they are mobilized into the circulation. In our study, we found that BM Ly6Chi monocytes are not a homogenous population, as
current data would suggest. Using computational analysis approaches to interpret multidimensional datasets, we demonstrate that BM
Ly6Chi monocytes consist of two distinct subpopulations (CXCR4hi and CXCR4lo subpopulations) in both mice and humans. Transcriptome
studies and in vivo assays revealed functional differences between the two subpopulations. Notably, the CXCR4hi subset proliferates and
is immobilized in the BM for the replenishment of functionally mature CXCR4lo monocytes. We propose that the CXCR4hi subset represents a transitional premonocyte population, and that this sequential step of maturation from cMoPs serves to maintain a stable pool
of BM monocytes. Additionally, reduced CXCR4 expression on monocytes, upon their exit into the circulation, does not reflect its diminished role in monocyte biology. Specifically, CXCR4 regulates monocyte peripheral cellular activities by governing their circadian
oscillations and pulmonary margination, which contributes toward lung injury and sepsis mortality. Together, our study demonstrates
the multifaceted role of CXCR4 in defining BM monocyte heterogeneity and in regulating their function in peripheral tissues.
Introduction
Monocytes arise from common monocyte progenitors
(cMoPs) in the BM (Hettinger et al., 2013) and develop into
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mature Ly6Chi monocytes before being released into the blood.
In comparison to other myeloid cells (Terashima et al., 1996),
monocytes have an exceedingly short transit time through the
BM and are rapidly released into the circulation after their last
division (Goto et al., 2003). Upon entering the circulation, Ly6Chi monocytes have a half-life of just 20 h before undergoing
terminal differentiation into longer-lived Ly6Clo monocytes
(with a half-life of 48 h;Varol et al., 2007; Hanna et al., 2011;
© 2016 Chong et al. This article is distributed under the terms of an Attribution–Noncommercial–Share
Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org
/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–
Share Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).
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CXCR4lo monocytes. Additionally, we provide new insights
into the role of CXCR4 in mediating the spatiotemporal localization of monocytes in peripheral sites by demonstrating
its role in diurnal oscillations and pulmonary margination. Importantly, disruption of CXCR4-signaling also led to reduced
lung injury and sepsis mortality.Together, our findings identify
a previously undefined developmental transition that exists
among BM Ly6Chi monocytes and demonstrates the multifaceted role of CXCR4 in their peripheral tissue responses.
Results
CXCR4 defines heterogeneity among BM Ly6Chi monocytes
It is now well established that cMoPs give rise to Ly6Chi
monocytes in the BM (Hettinger et al., 2013). However, it is
unclear whether BM Ly6Chi monocytes consist of a homogenous population or if further heterogeneity exists among
these cells. To address this question, we analyzed BM Ly6Chi
monocytes (excluding their progenitors) using an unsupervised dimensional reduction algorithm (distributed stochastic
neighbor embedding [t-SNE];Amir et al., 2013; Becher et al.,
2014) on flow cytometry data based on six common myeloid
cell markers, CXCR4, CD31, CD16/32, CX3CR1, CCR2,
and CD11b (Fig. 1 A). This approach allows us to visualize
multidimensional similarities of cells in a 2D scatter plot,
known as the t-SNE map, which results in enhanced visualization of small cellular subpopulations through cell clusters
with similar protein expression patterns (Amir et al., 2013;
Becher et al., 2014).Visualization of BM Ly6Chi monocytes
on the t-SNE map revealed heterogeneity among these cells,
which can be categorized into two main subsets through
automated clustering (Fig. 1 A). Upon examination of each
selected marker, we found that CXCR4 delineated BM Ly6Chi monocytes into two subsets that closely represented the
outcome generated by automated clustering (Fig. 1 B). Furthermore, CXCR4 segmentation resulted in the highest ratio
in median intensity between these two clusters (Fig. 1 C),
suggesting that CXCR4 could serve as a suitable surface
marker in delineating BM Ly6Chi monocyte heterogeneity.
Indeed, we found two distinct populations of Ly6Chi monocytes in the BM that consisted of a CXCR4hi and CXCR4lo
subset (Fig. 1 D). Furthermore, scanning electron microscopy
revealed morphological differences between these two subsets, with only the CXCR4lo subset protruding its cytoplasmic membrane upon adhering to coverslips (Fig. 1 E). We
also validate the presence of CXCR4-defined heterogeneity
among human BM monocytes and observed the presence of
CXCR4hi and CXCR4lo monocytes (Fig. 1 F). Collectively,
our results identify heterogeneity in the current established
BM Ly6Chi monocyte pool and the presence of a distinct
subpopulation that can be delineated through CXCR4.
Transcriptome profiling reveals distinct gene expression
signatures between BM CXCR4hi and CXCR4lo Ly6Chi monocytes
To further characterize the CXCR4hi and CXCR4lo
monocyte subsets, we sorted all cells in the monocyte
CXCR4 in monocyte development and lung margination | Chong et al.
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Mildner et al., 2013;Yona et al., 2013). It is therefore highly essential that circulating Ly6Chi monocytes are constantly being
replenished through the coordinated release of these cells from
the BM. Current evidence indicates that the release of BM Ly6Chi monocytes is governed by CCR2 and CX3CR1, with
the latter receptor reportedly influencing the survival of Ly6Clo
monocytes (Serbina and Pamer, 2006; Landsman et al., 2009;
Shi and Pamer, 2011; Jacquelin et al., 2013). CXCR4-signaling
also acts as an anchoring force that retains Ly6Chi monocytes in
the BM (Jung et al., 2015; Liu et al., 2015), whereas its inhibition
(Beaussant Cohen et al., 2012; McDermott et al., 2014) reverses
the observed monocytopenia present in patients with WHIM
syndrome (Warts, hypogamma-globulinemia, infections, and
myelokathexis; Hernandez et al., 2003; Gulino et al., 2004).
Although circulating monocytes have historically been
regarded as precursor cells that replenish tissue macrophages
and DC populations (Segura and Amigorena, 2013;Varol et al.,
2015), it is now increasingly being recognized that monocytes
exert potent effector functions at peripheral sites throughout the body (Mildner et al., 2013). Monocytes comprise
between ∼4 and 10% of total blood leukocytes and include
two major subsets that participate in host defense and tissue
repair (Ginhoux and Jung, 2014). In mice, Ly6Chi monocytes
resemble human CD14+CD16− classical monocytes (Cros et
al., 2010; Ingersoll et al., 2010; Wong et al., 2011) that express
multiple cytokines and granule-associated proteins for effector
functions at infectious and inflammatory sites (Serbina et al.,
2008). In contrast, murine Ly6Clo monocytes resemble human
CD14−CD16+ nonclassical monocytes (Cros et al., 2010; Ingersoll et al., 2010) that patrol and eliminate cellular debris
from blood vessel walls (Auffray et al., 2007; Carlin et al., 2013),
as well as control tumor metastasis in the lung (Hanna et al.,
2015). In addition, several studies have shown that monocytes
mediate the recruitment of leukocytes in response to pathological insults (Kreisel et al., 2010; Carlin et al., 2013), and are
essential for peripheral tissue repair during the resolution phase
(Nahrendorf et al., 2010). Consequently, their ability to be rapidly mobilized from the BM for their deployment to inflammatory sites, as well as to return to a state of homeostasis, is critical
for effective immune responses and prevention of collateral tissue damage. Furthermore, monocytes are progressively being
recognized as attractive targets for therapeutic interventions, as
lipid nanoparticles and antagonists that target monocytes have
shown therapeutic efficacy in several diseases (Leuschner et al.,
2011; Majmudar et al., 2013; Poupel et al., 2013). It is therefore
imperative that a better understanding of their cellular and molecular mechanisms be explored at multiple tissue levels.
Using a combination of computational analysis approaches coupled with transcriptome profiling and in vivo
assays, we identify a previously unknown heterogeneity that
exists among BM Ly6Chi monocytes in both human and
mice. Specifically, BM Ly6Chi monocytes consist of two distinguished subpopulations (CXCR4hi and CXCR4lo subpopulations) and that the immobilized CXCR4hi subset serves
as a transitional precursor for the replenishment of mature
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Figure 1. CXCR4 defines heterogeneity among BM Ly6Chi monocytes. (A) BM Ly6Chi monocytes were gated accordingly (left) and subjected to t-SNE
dimensional reduction (middle). Automatic clustering was performed using k-means, and clusters plotted into the t-SNE map (right). (B) Indicated markers
are color mapped from blue (low expression) to red (high expression) into the t-SNE map. (C) Overlayed histograms of indicated markers constructed from
data obtained from the k-means of cluster 1 (blue) and cluster 2 (red) that was generated from automated clustering. (A–C) Data are representative of one
out of three experiments with at least n = 3 samples. (D–E) BM Ly6Chi monocytes in mice divided into CXCR4hi (blue) and CXCR4lo (red) subsets (D) with
scanning electron microscopy images of mouse CXCR4hi (top) and CXCR4lo (bottom) subsets (E). Bars, 1 µm. Data are representative of one out of three
experiments. (F) Gating strategy and division of human BM classical monocytes into CXCR4hi (blue) and CXCR4lo (red) subsets. Data are representative of
one out of three experiments conducted with seven independent donors.

developmental pathway, specifically cMoPs, CXCR4hi,
and CXCR4lo Ly6Chi monocyte subsets, and Ly6Clo
monocytes from the BM (Fig. 2 A). Subsequently, we
JEM Vol. 213, No. 11

performed whole transcriptome sequencing using next
generation sequencing (NGS) on these cells to compare
their genome-wide RNA expression profiles. Princi2295
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Identification of a developmental relationship between BM
Ly6Chi monocyte subpopulations
To understand how the newly identified CXCR4hi subset
may relate to monocyte development in the BM, we first
compared the transcriptomic signature of the CXCR4hi
subset with signatures specific for both Ly6Chi and Ly6Clo
monocytes by Connectivity map (CMap) analysis (Fig. 3 A).
Notably, the CMap analysis is a gene-set enrichment analysis
algorithm that generates indicative scores of closeness to one
cell subset of a defined signature gene set (Lamb et al., 2006).
CMap analysis revealed a skewing of transcriptomic characteristics of the CXCR4hi subset toward the Ly6Chi but not
Ly6Clo monocyte signature, suggesting that the CXCR4hi
subset may be an intermediate precursor that bridges the
cMoP and the CXCR4lo subset (Fig. 3 A). Furthermore, optimal leaf ordering (OLO; Bar-Joseph et al., 2001) of transcriptomic data obtained from cMoP, CXCR4hi, and CXCR4lo
Ly6Chi monocytes produced a dendrogram that supports the
appearance of the CXCR4hi subset before the development
of the CXCR4lo subset (Fig. 3 B). To further understand the
developmental relationship and phenotypic changes that may
occur between the CXCR4hi and CXCR4lo subsets, we used
the Wanderlust algorithm, which orders single cells according
to their most immature to mature state into a constructed trajectory (Bendall et al., 2014). Based on FACS data that consisted of six parameters indicated in Fig. 1 B, we selected the
starting point as cells that expressed high levels of CXCR4,
CD31, and CD16/32 as observed on cMoPs (Fig. 2 E). Based
on these data, the Wanderlust algorithm computationally determined early events (i.e., immature cells) as CXCR4hiCD11bloCCR2loCX3CR1lo cells, whereas late events (i.e.,
mature cells) consisted of CXCR4loCD11bhiCCR2hiCX3
CR1hi cells (Fig. 3 C). Furthermore, we found that CXCR4,
CD31, and CD16/32 were down-regulated, whereas CCR2,
CX3CR1, and CD11b were up-regulated during the course
of BM Ly6Chi monocyte maturation (Fig. 3 D).These results
hence strongly suggest that the CXCR4hi subset may be a
precursor of the mature CXCR4lo subset. To confirm these
findings in vivo, we adoptively transferred sorted CXCR4hi
BM Ly6Chi monocytes into recipient mice and observed that
the CXCR4hi subset differentiated into the CXCR4lo subset (Fig. 3 E). Moreover, administration of BrdU into mice,
which allowed us to track the maturation of these cells, further
confirmed the CXCR4hi subset as an immediate precursor of
the CXCR4lo subset (Fig. 3 F). Notably, we did not detect
the presence of Ly6Clo monocytes upon the appearance of
Ly6Chi monocytes in these experiments (unpublished data).
We also provide evidence that CXCR4 is critically linked
to BM Ly6Chi monocyte maturation and that the CXCR4lo
subset represents mature Ly6Chi monocytes that eventually
egress into the bloodstream during homeostatic conditions
(Fig. 3, G and H; and Fig. S3). Collectively, our results describe a previously undefined developmental pathway of
monocytes and that the CXCR4hi subset acts as an immediate precursor of mature Ly6Chi monocytes.
CXCR4 in monocyte development and lung margination | Chong et al.
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pal-component analysis (PCA) of all expressed genes revealed distinct and well-separated transcriptomic profiles
(Fig. 2 B), implying that the CXCR4hi subpopulation
was clearly distinct from all other monocyte subsets in
the BM. In particular, comparative analysis of cMoP and
the CXCR4hi subset revealed an enrichment of genes
in the CXCR4hi subset that was predominantly associated with cell migration and monocyte function, such
as Fn1, Vcan, Ccr1, Lyz2, and Msr1 (Fig. 2 C). In contrast, cMoPs displayed an enrichment of self-renewal
genes, such as Cd34 and Kit, and neutrophil-associated
microbicidal activity genes such as Mpo, Ctsg, and Elane
(Fig. 2 C). Comparative analysis of the CXCR4hi to
CXCR4lo subset also revealed a significantly large enrichment of cell cycle–dependent genes in the CXCR4hi
subset, such as Ccnf, Top2a, Mki67 and Cdk1. In contrast,
the CXCR4lo subpopulation displayed an enrichment of
monocyte effector function genes such as Cd14, C5ar1,
Nod2, and Il1b (Fig. 2 C). Biofunction enrichment analysis using Ingenuity pathway analysis (IPA; Fig. 2 D) and
heat maps (Fig. S1) of gene expression data further confirmed these findings. In particular, the CXCR4hi subset
was found to be functionally more mature than cMoPs
but less mature than the CXCR4lo subset. We also discovered several candidate surface markers that allow the
discrimination of the CXCR4hi subset from the CXCR4lo
subset and cMoPs (Fig. 2 E and Fig. S2).
Although BM Ly6Chi monocytes have been thought
to be terminally differentiated cells that proliferate minimally in the steady state (van Furth et al., 1979), the
enrichment of cell cycle genes in the CXCR4hi subset
prompted us to determine if these cells may proliferate in
vivo. To address this, we used a fluorescence ubiquitin cell
cycle indicator (Fucci) transgenic mouse that labels for
cells in the S and G2/M phase of the cell cycle. Although
the CXCR4lo subset and Ly6Clo monocytes were not fluorescent for Fucci, the CXCR4hi subset and cMoP were
found to be Fucci+ and actively cycling in the S/G2/M
phase (Fig. 2 F). BrdU incorporation assays further revealed that the majority of cells belonging to the CXCR4hi
subset were in the S phase of the cell cycle, in contrast
to the CXCR4lo subset that was in the G0/G1 phase
(Fig. 2 G). Furthermore, we made similar observations
in human BM cells (Fig. 2 H). Specifically, the CXCR4hi
subset was found to be actively replicating in the S phase
of the cell cycle through BrdU incorporation in vitro and
expressed slightly lower levels of CD14 and CD11b but
higher levels of HLA-DR (Fig. 2 H). To complement our
phenotypic studies, we performed an in vivo bead uptake
assay and confirmed that the CXCR4hi subset was functionally less active than the CXCR4lo subset through reduced bead uptake in vivo (Fig. 2 I). Collectively, our data
distinguishes the CXCR4hi subset as a distinct subpopulation that differs phenotypically and functionally from the
CXCR4lo subset of Ly6Chi monocytes.
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The CXCR4hi subset functions as a transitional
precursor for the replenishment of active CXCR4lo
mature Ly6Chi monocytes
The circadian rhythmic release of immune cells, in particular
hematopoietic stem cell progenitors and monocytes, from the
BM into the circulation represents a fundamental physiological process that is integral for host defense and homeostasis
(Nguyen et al., 2013; Scheiermann et al., 2013). Because our
current results identify BM Ly6Chi monocytes as a heterogeneous population (Figs. 1, 2, and 3), we therefore examined
JEM Vol. 213, No. 11

their behavior at different periods of the circadian rhythm.
Here, we observed that only the mature CXCR4lo subset,
but not the CXCR4hi subset, cMoP, or Ly6Clo monocytes,
in the BM oscillated in numbers according to the circadian
rhythm (Fig. 4 A). Although the CXCR4hi subset did not
exhibit changes in CXCR4 expression, the CXCR4lo subset
exhibited lower CXCR4 expression and a reduced number
in the BM at ZT5 (zeitgeber 5; 5 h after the onset of light)
and a higher CXCR4 expression and number at ZT13 (at
the beginning of the active phase; Fig. 4 B). These results
2297
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Figure 2. Transcriptomics reveal distinct
expression signatures between the CXCR4hi
and CXCR4lo Ly6Chi monocyte populations.
(A–E) BM cMoP, CXCR4hi, and CXCR4lo Ly6Chi
subsets and Ly6Clo monocytes were sorted
from three individual mice according to the
gating strategy (A), and then RNA extracted for
NGS. (B) PCA of gene expression. (C) Volcano
plots depicting the log2 fold change between
cMoP and CXCR4hi subset (top) and CXCR4hi
and CXCR4lo subset (bottom) versus the
−log10 FDR. (D) Biofunction enrichment analysis of the top gene-ontology processes that
are enriched when comparing cMoP versus
CXCR4hi subset (top) and CXCR4hi versus
CXCR4lo subset (bottom) using IPA. (E) Heat
maps of gene expression (log2 CPM; top) and
surface markers validated by flow cytometry (log2 MFI; bottom). Flow cytometry data
are representative of one out of three experiments. (F) Frequency of proliferating cells
among BM monocyte subsets determined by
Fucci-474 mice in vivo. Numbers in histograms
(top) represent percentage of proliferating
cells. Results (bottom) are expressed as mean ±
SD (n = 3) and representative of two independent experiments. ****, P < 0.0001 (one-way
ANOVA). (G) Mouse monocyte subsets in cell
cycle stages assessed through BrdU incorporation in vivo. Results are expressed as mean
± SD (n = 5) and representative of two independent experiments. ****, P < 0.0001 (oneway ANOVA). (H) Human BM cells were pulsed
with 10 µM of BrdU in vitro and monocytes in
the S phase (left) were found to be CXCR4hi,
CD11blo, CD14lo, and HLA-DRhi (right). Results
are representative of one out of four independent donors. (I) BM mouse monocytes subsets
were assessed for their uptake of microspheres
in vivo after 4 h through flow cytometry. Results are expressed as mean ± SD (n = 5) and
representative of two independent experiments. **, P < 0.01 (one-way ANOVA).
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hence suggest that both subsets of monocytes may display
a difference in their mobilizing capacity. Therefore, we next
determined how a strong mobilizing cue, such as LPS (Shi et
al., 2011; Evrard et al., 2015), may impact their mobilization.
Intriguingly, we observed that LPS administration resulted in
the egress of the CXCR4lo subset and Ly6Clo monocytes,
but not the CXCR4hi subset and cMoP in the BM (Fig. 4,
2298

C and D). Further analysis demonstrated that the CXCR4hi
subpopulation displayed a much lower surface expression of
CCR2 (Fig. 4 E), which led to a drastically poorer migration
toward the cognate ligand CCL2 (Fig. 4 F). Together with
our transcriptomic and functional data (Fig. 2), our results
hence indicate that the CXCR4hi subpopulation is essentially
immobilized in the BM under both homeostatic and inflamCXCR4 in monocyte development and lung margination | Chong et al.
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Figure 3. Identification of a developmental relationship between subpopulations
of BM Ly6Chi monocytes. (A) CMap analysis
of cMoP, CXCR4hi subset, CXCR4lo subset, and
Ly6Clo monocytes displaying their enrichment
for Ly6Chi or Ly6Clo monocyte gene sets. (B)
OLO reveals a computationally determined developmental order that starts with the cMoP
and ends with the CXCR4lo subset as the most
mature cell type. (A and B) Data were analyzed
using transcriptomic data obtained from three
individual mice. (C and D) BM Ly6Chi monocytes subjected to the Wanderlust algorithm
using flow cytometry data of six parameters.
Data are representative of one out of three
independent experiments. (C) Events were
plotted against the wanderlust parameter
with low and high values representing early
and late predicted events, respectively. Early
and late events were next plotted for CXCR4
expression against CD11b, CCR2, and CX3CR1.
(D) Wanderlust traces showing low CXCR4,
CD31, and CD16/32 during the early trajectory
(0–0.5), and an increase in CX3CR1, CCR2, and
CD11b during the late trajectory (0.5–1). (E) Intrafemoral transfer of sorted CD45.1+ CXCR4hi
subset into CD45.2 recipients. Blue dots represent transferred cells after 8 and 24 h. Results
are representative of one out of five mice in
three independent experiments. (F) FACS plots
of BrdU+ (blue) and BrdU− (red) Ly6Chi monocytes after BrdU administration. Results are
representative of one out of five independent
mice. (G) Alteration in CXCR4 expression over
time among BM Ly6Chi monocytes (left) and
percentage of BrdU+ Ly6Chi monocytes in the
blood (right) at various time points. ΔMFI was
calculated by subtracting the CXCR4 MFI of
BrdU− Ly6Chi monocytes from that of BrdU+
Ly6Chi monocytes (as described in Fig. S3). Results are expressed as mean ± SEM (n = 5) and
representative of one out of two independent
experiments. (H) Graph showing correlation
between blood BrdU+ Ly6Chi monocytes and
ΔMFI of CXCR4 in the BM. Each dot represents
one data time point and significance was determined using a Pearson correlation test.
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Downloaded from on December 1, 2016

Figure 4. BM Ly6Chi monocyte subpopulations represent two distinct mobilizable pools. (A and B) BM monocyte subsets (cMoP, CXCR4hi and CXCR4lo
Ly6Chi monocytes, and Ly6Clo monocytes) were quantified for their numbers (A) and their normalized CXCR4 MFI (B) at ZT5 and ZT13. Results are expressed
as mean ± SD (n = 4–5) and representative of one out of three experiments. ns, not significant; *, P < 0.05; **, P < 0.01 (Student’s t test). (C) BM monocyte
subset counts after LPS administration. Results expressed as mean ± SD (n = 5) and representative of one out of five independent experiments. *, P < 0.05;
**, P < 0.01; ***, P < 0.001 (one-way ANOVA). (D) BrdU+ CXCR4hi and CXCR4lo subset counts after 2 h of LPS administration. Results expressed as mean ± SD
(n = 5) and representative of one out of three independent experiments. ns, not significant; ***, P < 0.001 (Student’s t test). (E) CCR2 expression (left) and
CCR2 MFI (arbitrary units; right) of CXCR4hi and CXCR4lo subsets. Results are expressed as mean ± SEM (n = 5). ****, P < 0.0001 (Student’s t test). (F) Chemotaxis assay of CXCR4hi and CXCR4lo subsets towards CCL2. Results expressed as mean ± SD (n = 5) and representative of two independent experiments.
*, P < 0.05; **, P < 0.01 (two-way ANOVA).

matory conditions to serve as a transitional precursor for the
replenishment of CXCR4lo mature monocytes.
CXCR4 mediates circadian rhythmic oscillations of mature
monocytes and their homing into reservoirs
In contrast to the heterogeneity observed in the BM, we found
that circulating Ly6Chi monocytes (Fig. S4) were exclusively
CXCR4loCD11bhi cells (Fig. 5 A). However, it remains unclear if the reduced expression of CXCR4 upon their exit
JEM Vol. 213, No. 11

from the BM indicates its diminished role in peripheral tissue
compartments. Because BM CXCR4loLy6Chi monocytes was
found to exhibit diurnal fluctuations in CXCR4 expression
(Fig. 4, A and B), we hence examined whether such physiological and cellular rhythms could also occur among circulating monocytes. We also determined if CXCR4 mediates
these physiological processes by studying their diurnal oscillations in a conditional knockout mouse (Lyz2creCxcr4fl mice)
that permits efficient and selective deletion of the Cxcr4 gene
2299
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in myeloid lineage cells, such as monocytes and neutrophils
(Clausen et al., 1999; Fig. 5, B and C). Indeed, we found
that circulating monocytes exhibited fluctuations in CXCR4
expression (Fig. 5, D and E) that corresponded to the high
and low number of circulating Ly6Chi (Fig. 5 D) and Ly6Clo
monocytes (Fig. 5 E) at ZT5 and ZT13, respectively. More
importantly, this diurnal oscillation in monocyte numbers was
abrogated in the absence of CXCR4 (Fig. 5, D and E) and
highlights the role of CXCR4 in mediating the diurnal variations in circulating monocyte numbers.
Although it is likely that circadian-mediated fluctuations in CXCR4 expression could influence the release of
monocytes from the BM and impact on the overall numbers
of circulating monocytes, we hypothesize that this process
may also act on the trafficking patterns of monocytes in pe2300

ripheral compartments.To test this hypothesis, we established
parabiosis between CD45.1 WT mice and CD45.2 CXCR4
genetic-modified mice (Fig. 6, A and B). CXCR4 genetic-modified mice included either Lyz2creCxcr4fl mice or a
knock-in mouse strain that carries a CXCR4 gain-of-function
mutation characteristic of WHIM patients (termed Cxcr4WHIM
or WHIM mice; Balabanian et al., 2012; Beaussant Cohen
et al., 2012; McDermott et al., 2014). The homing ratio of
cells were then calculated (Fig. 6 A) to normalize for their
chimerism (Fig. 6 C). Using this approach, we observed a
significant decrease in the homing of Lyz2creCxcr4fl monocytes to the BM (Fig. 6 A). This trend was similarly observed
with neutrophils (Fig. 6 A) and is consistent with the known
requirement of CXCR4 in mediating their homing to the
BM (Martin et al., 2003; Suratt et al., 2004; Devi et al., 2013).
CXCR4 in monocyte development and lung margination | Chong et al.
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Figure 5. CXCR4 regulates circadian rhythmic oscillations of monocytes. (A) Representative FACS plot of CXCR4 and CD11b expression by blood
Ly6Chi monocytes (gating strategy in Fig. S4) of one out of four independent experiments. (B) Representative FACS plot depicting loss of CXCR4 expression
in Lyz2creCxcr4fl mice (blue) as compared with Cxcr4fl controls (red) of one out of three independent experiments. (C) Comparison of blood leukocyte
populations in RosamT/mG:Lyz2cre mice and RosamT/mG:Lyz2creCxcr4fl mice showing the percentage of Lyz2-cre mediated recombination (GFP+) at the Rosa26
locus (left) and normalized CXCR4 MFI (arbitrary units) of circulating leukocyte subsets (right). Results are expressed as mean ± SD (n = 4–5 mice per group).
ns, not significant; *, P < 0.05; **, P < 0.01; ****, P < 0.0001 (two-way ANOVA). (D and E) Blood Ly6Chi (D) and Ly6Clo (E) monocyte values of normalized
CXCR4 MFI on Cxcr4fl control mice (left) and counts between Cxcr4fl control and Lyz2creCxcr4fl mice (right) were quantified at ZT5 and ZT13. Data are
representative of one out of three experiments. Results are expressed as mean ± SD (n = 5 mice per group). ns, not significant; **, P < 0.01; ***, P < 0.001;
****, P < 0.0001 (Student’s t test).
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Circulating monocytes accumulate in the pulmonary
vasculature after endotoxin exposure
It is well established that LPS administration is a potent mediator that mobilizes monocytes from the BM, and consequently results in increased circulating monocyte numbers
(Shi et al., 2011; Evrard et al., 2015). However, we consistently
observed a transient phase of monocytopenia in the blood
that occurs one hour after LPS administration (Fig. 7 A),
which corresponded to a time point whereby no significant
changes in monocyte numbers were detected in the BM
(Fig. 4 C). These results hence suggest that blood monocytes were possibly being withdrawn temporarily from the
circulation into other tissues. To address this hypothesis, we
adopted an intravascular staining protocol (Reutershan et al.,
2005; Ng et al., 2011; Anderson et al., 2014; Fig. 7 B), which
allowed discrimination between intravascular or extravascular
cell distributions in tissues in vivo. In the lung, this approach
confirmed the extravascular location of alveolar macrophages,
whereas monocytes and neutrophils were identified as being
intravascular (Fig. 7 C). Using this method, we found that
the LPS-induced decrease in circulating monocytes was accompanied by a gradual accumulation of these cells in the
intravascular compartment of the lung (Fig. 7, D and E),
with limited monocyte sequestration into other major organs
(spleen, liver, and kidney; unpublished data). Furthermore, this
phenomenon was mediated by the intrinsic sensing of LPS by
monocytes and not vascular stromal cells, as our BM chimeric
data demonstrated an abrogation of monocyte accumulation
in the lung in the absence of TLR4 in the hematopoietic
compartment (Fig. 7 F). Therefore, these data suggests that
circulating monocytes are transiently withdrawn from the
circulation and sequestered into the lung microvasculature in
response to systemic inflammatory stimuli.
JEM Vol. 213, No. 11

CXCR4 regulates monocyte margination in
the pulmonary vasculature
To delineate the mechanism of LPS-induced monocyte accumulation in the lung, we used intravital two-photon microscopy to visualize the pulmonary microvasculature of
Cx3cr1gfp/+ reporter mice. Endotoxin exposure stimulated
blood monocytes to alter their morphology and decrease
their velocity in the lung capillaries, which are characteristic features of margination (Doerschuk et al., 1993; Kuebler
and Goetz, 2002; Looney and Bhattacharya, 2014; Fig. 8 A
and Video 1). Because lung endothelial cells express CXCL12
(Devi et al., 2013), we speculated that the CXCL12–CXCR4
signaling axis might be involved in monocyte margination
in the lung. To test this hypothesis, we treated Cx3cr1gfp/+
mice with AMD3100 and observed monocytes traveling
through the lung microcirculation at a higher velocity and
with significant reduced adherence to the endothelium, even
in mice that were treated with the promargination stimulus
LPS (Fig. 8, B and C; and Video 1). FACS analysis further
supported these data, as shown by increased accumulation of
lung monocytes in WHIM mice after LPS challenge, whereas
this phenomenon was abrogated in Lyz2creCxcr4fl mice
(Fig. 8 D). Because it is well known that Ly6Chi monocytes
also express lower levels of GFP in Cx3cr1gfp/+ mice (Auffray
et al., 2007), we ensured that our approach was able to detect
Ly6Chi monocytes during intravital imaging by administering
an anti-Ly6B.2 antibody into Cx3cr1gfp/+ mice to stain these
cells in vivo (Fig. 8, E and F; and Video 2) and confirmed that
our imaging approach accounted for these cells.
We next further determined whether CXCR4 regulated monocyte margination equally in both subsets. By
using a lung efflux assay to quantify monocyte release from
the pulmonary circulation (Devi et al., 2013; Fig. 9 A) without the interference from interposing organs (Bierman et
al., 1952), we observed that AMD3100 treatment increased
the net release of both Ly6Chi and Ly6Clo monocytes from
the lungs (Fig. 9 B). However, only the Ly6Chi subset displayed a significant increase in lung retention following
LPS and this process could be prevented with the preadministration of AMD3100 (Fig. 9 B). To extend these findings in the context of humans, we found that AMD3100
also markedly increased circulating CD14+CD16− classical
monocytes in humanized mice, which was accompanied
by an increased net release of these cells from the pulmonary circulation (Fig. 9, C and D). This phenomenon was
similarly observed in an experimental model of non-human primates (Fig. 9 E).
The accumulation of myeloid cells in the lung is a hallmark of injury in pulmonary diseases (MacNee and Selby,
1993). It is thus likely that an increase in margination in
the lung endothelium may predispose toward tissue injury.
To test this hypothesis, we used a model of acute lung injury (ALI; O’Dea et al., 2009) and found that Lyz2creCxcr4fl
mice displayed a significant decrease in vascular leakage compared with the Cxcr4fl control mouse (Fig. 9 F). Further2301
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In contrast, no significant differences in T cell homing ratio
were observed between the Lyz2creCxcr4fl and WT parabionts
as T cells are not targeted by the Lyz2cre-mediated deletion
of CXCR4 (Eash et al., 2009; Fig. 6 A) and confirms that
our earlier observations on monocytes are cell intrinsic and
specifically mediated by CXCR4. In contrast, WHIM mice
exhibited a corresponding increase in monocyte homing to
the BM in their WT partners (Fig. 6 B). Adoptive transfer
experiments further confirmed these findings, as CD45.1 BM
monocytes that were transferred into CD45.2-recipient mice
were observed to rapidly decline in the blood and accumulate
in the BM via a mechanism that was disrupted by AMD3100
treatment (Fig. 6, D and E). Interestingly, we also observed a
significant decrease in the homing of Lyz2creCxcr4fl monocytes into the spleen (Fig. 6 A). Conversely, there was a trend
toward an increased homing of WHIM monocytes into the
spleen (Fig. 6 B). Collectively, our data highlights a role for
CXCR4 in mediating the circadian rhythmic fluctuations in
the overall number of circulating Ly6Chi monocytes and their
homing into tissue reservoirs.
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Figure 6. CXCR4 regulates homing of monocytes back to reservoirs. (A and B) Homing capacity (calculated as a ratio) of monocytes or indicated
immune cells of WT and Lyz2creCxcr4fl (A) or Cxcr4WHIM (B) into the BM or spleen of their respective partners in parabiotic mice. Monocyte, neutrophil and T
cell numbers were quantified in blood, BM and spleen before calculation of the respective homing ratios to normalize for unequal exchange in circulating
leukocytes (n = 4–5). ns, not significant; *, P < 0.05; **, P < 0.01 (Student’s t test). Results are representative of one out of two independent experiments.
(C) Percentage of nonhost cells present in blood of WT and Lyz2creCxcr4fl mice (left), and WT and Cxcr4WHIM parabiotic mice (right). Results are expressed as
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more, Ly6Chi monocytes did not accumulate in the lungs of
Lyz2creCxcr4fl mice in a high-grade cecal ligation and puncture
(CLP) model of sepsis (Fig. 9 G) and exhibited a significant
improved survival outcome compared with Cxcr4fl control
mice (Fig. 9 H). Together, these data suggest that CXCR4
continues to play important roles in regulating monocyte
margination in the pulmonary circulation, whereas disruption
of its signaling ameliorated lung injury and sepsis mortality.

mean ± SD (n = 4–5) and representative of one out of two independent experiments. (D and E) Total number of donor (CD45.1+) monocytes with a Ly6Chi
(left) or Ly6Clo (right) phenotype detected in blood (D) or BM (E) in recipient CD45.2+ mice that had been pretreated with or without AMD3100. Results are
expressed as mean ± SD (n = 4) and representative of one out of three independent experiments. *, P < 0.05; **, P < 0.01; ***, P < 0.001 (two-way ANOVA).
JEM Vol. 213, No. 11
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Discussion
In this study, we report the discovery of heterogeneity among
BM Ly6Chi monocytes. Specifically, BM Ly6Chi monocytes
consist of two developmentally related subsets of monocytes
(CXCR4hi and CXCR4lo subpopulations) that are functionally distinct in their immunological roles. Furthermore, we
extend the role of CXCR4 beyond its reported function as a
mere BM anchoring signal by demonstrating its involvement
in the control of monocyte tissue trafficking activities. Specifically, we reveal that CXCR4 controls monocyte margination
in the lung vasculature and contributes to lung injury and
sepsis-induced mortality. Our study hence provides a conceptual advancement in the understanding of monocyte biology
by identifying the presence of a transitional precursor population among BM Ly6Chi monocytes and deciphering the
peripheral mechanisms that control monocyte homeostasis
in the tissue (Fig. 10).
Using a combination of computational analytical approaches and flow cytometric analysis, we observed that
cMoP-derived BM Ly6Chi monocytes consist of two distinct
subpopulations defined by CXCR4 expression. Isolation of
these cells revealed that CXCR4hi and CXCR4lo subpopulations are transcriptionally distinct. In particular, the CXCR4hi
subpopulation was enriched in genes associated with cell
cycle, cell division, and DNA repair whereas the CXCR4lo
subpopulation was over-represented with genes associated
with cellular activation, phagocytosis, motility, and pattern
recognition. Comparative analysis of the CXCR4hi subpopulation with its progenitor, cMoP, also revealed distinct genetic
differences, with the CXCR4hi subset displaying a more mature phenotype than cMoPs. Our results hence suggest that
a considerable amount of functional maturation continues to
occur in the CXCR4hi subpopulation. Consistent with this
notion, results from our functional studies validated that the
CXCR4hi subpopulation is actively proliferating and displayed reduced bead internalization in vivo compared with
the CXCR4lo subpopulation. More importantly, we show that
the CXCR4hi subpopulation gives rise to mature CXCR4lo
Ly6Chi monocytes over time. Furthermore, this CXCR4hi
subpopulation, like cMoPs, remains immobilized in the BM
even under inflammatory conditions and is insensitive to-

ward circadian rhythmic fluctuations. Together, we propose
that the CXCR4hi subpopulation of BM Ly6Chi monocytes
represents a population of transitional premonocytes (TpMo).
It is noteworthy that although Hettinger et al. (2013) have
shown the cMoP to be the only subset in the BM monocyte
fraction to form colonies and is committed strictly toward
monocyte development, it remains unclear if cMoPs are fully
committed toward the Ly6Chi monocyte lineage, or may give
rise to Ly6Clo monocytes independent of their differentiation
from Ly6Chi monocytes (Thomas et al., 2015). Because our
CMap analysis and in vivo data strongly demonstrates a linear
development of Ly6Chi monocytes from TpMo, it is likely
that the loss of c-kit on TpMo represents a loss of self-renewal
ability (Ogawa et al., 1991) upon their differentiation from
cMoPs, and that TpMos differ from cMoPs by serving as the
first fully committed and immediate precursor of mature Ly6Chi monocytes. More importantly, we believe that this newly
defined developmental transition forms a regulatory checkpoint that prevents an uncontrolled release and allows for
the rapid replenishment of BM monocytes. Our results also
suggest a new working model whereby monocytes program
their intrinsic mobilizing capacity according to their functional maturity, which ensures that only functionally mature
monocytes are being mobilized into the circulation.
It is well established that CXCR4-signaling plays a critical role in multiple biological processes in the BM compartment (Nagasawa, 2014). Consequently, studies have implicated
a role for CXCR4 in monocyte retention in the BM (Jung
et al., 2015; Liu et al., 2015). However, it remains unclear if
reduced expression of CXCR4 on monocytes, upon their
exit from the BM, indicates its diminished role in monocyte
biology in the circulation. Contrary to this assumption, we
observed that CXCR4 functions as an important mediator
in the spatiotemporal localization of monocytes in peripheral compartments. Notably, monocytes have been shown
to shuttle back to the BM through an unknown mechanism
(Varol et al., 2007). Using parabiosis and adoptive transfer
approaches, we provide the first experimental evidence of
CXCR4-mediated BM homing as a key mechanism in regulating circulating monocyte numbers, which is in line with
postulations discussed by Wang et al. (2009). Furthermore, we
found a similar trend in CXCR4-dependent homing into the
spleen, which further supports the idea that the spleen contains a reservoir of bona fide monocytes (Swirski et al., 2009)
that is not simply synonymous with the blood pool. Although
we believe that the BM remains the major compartment
where circulating monocytes home to as the spleen reservoir (Swirski et al., 2009) and its CXCL12 expression (Inra
et al., 2015) are much smaller than that of the BM, splenic
monocytes are mobilized during vascular and ischemic injury
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Figure 7. Endotoxemia promotes monocyte retention in the pulmonary circulation. (A) Blood Ly6Chi (top) and Ly6Clo (bottom) monocyte counts after
i.v. treatment with 10 ng LPS. Results are expressed as mean ± SEM (n = 4) and representative of one out of three independent experiments. ns, not significant; *, P < 0.05; **, P < 0.01; ****, P < 0.0001 (one-way ANOVA). (B) Illustration showing the intravascular labeling of leukocytes with anti-CD45 antibodies.
(C) Representative flow cytometry plots showing the extravascular and intravascular localization of lung immune cells of one out of three independent
experiments. (D and E) Quantification of Ly6Chi (left) and Ly6Clo (right) monocytes in blood (D) and lung tissues (E) from LPS-treated mice. Results are expressed as mean ± SEM (n = 4) and representative of one out of four experiments. ns, not significant; *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001
(one-way ANOVA). (F) WT and Tlr4−/− chimeric mice were analyzed for Ly6Chi monocyte numbers after 1 h of LPS administration. Each data point represents
one individual mouse and results are representative of two individual experiments. ns, not significant; **, P < 0.01 (one-way ANOVA).
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and increase in numbers through extramedullary hematopoiesis (Leuschner et al., 2012; Robbins et al., 2012). Therefore,
future work would be required to determine the extent of
monocyte homing to the spleen in these scenarios.
Leukocytes rely heavily on the circulatory system to
transport themselves to various tissues/organs. During this
trafficking process, leukocytes may interact with endothelial
cells for prolonged periods of time, which determines their
JEM Vol. 213, No. 11

transit time in organs. However, the functional outcomes of
these leukocyte intravascular activities have been underappreciated. It has been proposed that the marginated pool is
caused by the need for leukocytes to alter their morphology
as they transit and crawl through small-caliber microvessels
(Kuebler and Goetz, 2002). In particular, the lung represents
a major site of leukocyte margination (Staub and Schultz,
1968; Hogg, 1987) and is the only organ to receive the full
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Figure 8. Monocytes marginate in the
pulmonary vasculature. (A) A representative
GFP+ monocyte (arrowhead) alters its morphology through pulmonary capillaries. Bar,
15 µm (time, h:mm:ss; green, CX3CR1+ cells;
red, TRI
TC-dextran). Results are representative of one out of three independent experiments. (B and C) Monocyte mean velocity (B)
and duration of adherence (C) after indicated
treatments. Results are pooled from three independent experiments per treatment and are
expressed as mean ± SEM. ns, not significant;
**, P < 0.01; ***, P < 0.001; **** P < 0.0001 (oneway ANOVA). (D) LPS-induced fold-increase in
lung Ly6Chi (left) and Ly6Clo (right) monocytes
1 h after treatment. Results expressed as mean
± SEM (n = 4–7). ns, not significant; *, P < 0.05;
***, P < 0.001 (one-way ANOVA). (E) Snapshots
of GFP+ monocytes in the lung of a Cx3cr1gfp/+
reporter mouse, before (top) and after (bottom) i.v. administration of a Ly6B.2-PE antibody (4 µg). A representative GFP+ monocyte
is depicted migrating through pulmonary
capillaries (white track), becomes PE+ after antibody administration Bar, 15 µm (time, h:mm:ss; green, CX3CR1+ cells; red, Ly6B.2+ cells;
blue, Evans blue). Results are representative
of one out of three independent experiments.
(F) FACS plots of lungs from Cx3cr1gfp/+ mice
i.v. injected with Ly6B.2-PE. Ly6Chi (red), Ly6Clo
monocytes (orange), and neutrophils (green)
were plotted in relation to Ly6B.2 expression.
Results are representative of one out of three
independent experiments.
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Figure 9. CXCR4 regulates pulmonary monocyte margination and predisposition to injury. (A) Schematic of the lung efflux assay. (B) Monocyte
numbers released from the lung vasculature after indicated treatments. Results expressed as mean (n = 5–7 per group) and representative of one out of
three independent experiments. ns, not significant; *, P < 0.05; **, P < 0.01; ***, P < 0.001 (one-way ANOVA). (C and D) Frequency of blood (C) and pulmonary
release (D) of CD14+CD16− classical monocytes in humanized mice at baseline and 2 h after AMD3100 treatment (n = 8–11). Results are representative
of one out of two independent experiments. **, P < 0.01 (Student’s t test). (E) Net monocyte release from the lungs of two individual nonhuman primates
(Macaca fascicularis) over a 4-h observation period. (F–H) Lyz2creCxcr4fl mice were compared with Cxcr4fl control mice for lung vascular leakage during
acute lung injury (F; n = 5; **, P < 0.01, Student’s t test) or fold-increase accumulation of lung Ly6Chi (left) and Ly6Clo (right) monocytes (G; n = 3–5; ***, P <
0.001, Student’s t test) and their mortality using the Kaplan-Meier survival curve (H; n = 10; ****, P < 0.0001, Mantel-Cox) in the CLP sepsis model. Results
are representative of one out of three independent experiments.

cardiac output. Previous studies have shown that leukocyte
margination depends on a balance between the propelling
force executed by the shear stress of blood flow (Martin et al.,
1982) and a retaining force that delays monocyte transit. Data
from our intravital imaging and lung efflux experiments suggest that CXCR4 interactions partly constitute the retention
force in the lung vasculature. Importantly, we were able to
successfully replicate these findings in both humanized mice
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and in a nonhuman primate model, suggesting that CXCR4
regulation of monocyte margination is likely to be physiologically relevant in humans.
Although leukocyte margination is a fundamental
physiological process, their dysregulated intravascular migration and uncontrolled aggregation are associated with several human inflammatory diseases (MacNee and Selby, 1993;
Looney and Bhattacharya, 2014). Here, we show that LPS
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triggers increased pulmonary accumulation of inflammatory
Ly6Chi monocytes that leads to lung injury but is ameliorated
by CXCR4 inhibition. On the other hand, it appeared that
CXCR4 did not play a significant role in Ly6Clo monocyte
margination during endotoxemia, suggesting that Ly6Clo
monocytes may use a different array of molecules to interact
with the endothelium, such as integrins, as supported by a
previous study (Carlin et al., 2013). Nevertheless, our study
provides a mechanistic understanding of how CXCR4 antagonism may attenuate lung inflammatory diseases, as described
by previous studies (Lukacs et al., 2002; Drummond et al.,
2015). Furthermore, we show that interfering with CXCR4
signaling results in reduced monocyte accumulation in the
lung, which was associated with increased sepsis survival. Notably, although monocytes are essential for bacteria clearance,
they are also major contributors of the cytokine storm that
JEM Vol. 213, No. 11

leads to organ damage and mortality (Weber et al., 2015). Furthermore, monocyte depletion during ALI has been shown to
improve the outcome of vascular injury (O’Dea et al., 2009;
Dhaliwal et al., 2012). However, it is important to note that
more experimental work would be required to determine the
immune and organ-specific contexture of monocyte margination in the lung. Hence, our study shows that CXCR4-mediated monocyte compartmentalization may serve as a major
biological regulatory mechanism that underlies immune homeostasis to prevent excessive damage to the host.
In summary, our study provides new insight into the
current framework of monocyte development and homeostasis by identifying a previously undescribed population of
TpMo among BM Ly6Chi monocytes. Furthermore, our results extend the role of CXCR4 beyond its function as a BM
retentive force to an important regulator in the peripheral
2307
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Figure 10. CXCR4 identifies a TpMo population in the BM and mediates monocyte
cellular responses in peripheral tissues.
(top) Monocytes arise from cMoPs and undergo a developmental pathway that ends
with Ly6Clo monocytes as the terminally differentiated form of monocytes. In this study,
we propose that cMoP-differentiated Ly6Chi
monocytes undergo a developmental transition, which involves a transitional premonocyte (TpMo) stage, before giving rise to mature
Ly6Chi monocytes. TpMos are identified based
on their CXCR4hi expression compared with
mature Ly6Chi monocytes that are CXCR4lo.
Furthermore, TpMos can be distinguished from
cMoPs based on their negative expression for
c-kit. Functionally, TpMos are immobilized
in the BM to serve as an immediate precursor for the active pool of mature CXCR4lo
Ly6Chi monocytes. (Bottom) Upon entering
the circulation, CXCR4 plays a significant
role in monocyte margination in the pulmonary vasculature. Exposure to subclinical LPS
doses triggers increased pulmonary monocyte margination, leading to a transient state
of monocytopenia that can be reversed with
CXCR4 inhibition using AMD3100. Disruption
in CXCR4 signaling also attenuated lung injury
and prevented sepsis mortality.
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tissue compartment with implications in pulmonary inflammation. Hence, we envision that our results will provide a
new framework for understanding monocyte biology and
may lead to the engineering of improved monocyte-targeting
therapeutic strategies.

Tissue preparation for flow cytometry and sorting
Blood was obtained via cardiac puncture or incision in the
submandibular region and was then treated with commercialgrade red blood cell lysis buffer (eBioscience). Lungs were
removed en bloc in experiments looking at pulmonary
margination and mice were perfused with PBS containing
2 mM EDTA using a peristaltic pump (MIN
IPU
LS 3;
Gilson), followed by removal of the spleen and femurs. Lungs
and spleens were finely minced and homogenized to singlecell suspensions using 70-µm nylon mesh sieves with syringe
plungers (O’Dea et al., 2009). Mice femurs were flushed
and the effluent passed through a 70-µm nylon mesh sieve
to obtain a BM cell suspension. Human BM mononuclear
cells were purchased from Lonza and processed according to
the manufacturer’s instructions. Antibodies were purchased
2308

BrdU pulsing and proliferation assays
For in vivo assays, mice were administered 1.5 mg BrdU (BD)
via intraperitoneal injection at indicated time points for cell
tracking or for 30 min to assess their proliferative capacity.
For in vitro cell proliferative assays, human BM cells were
pulsed with 10 µM of BrdU for 45 min. To detect BrdU incorporation into monocytes, cells were surface-stained, fixed,
permeabilized, and subjected to intracellular staining with
FITC-conjugated anti-BrdU antibody, together with 7-AAD
for cell cycle analysis, according to the manufacturer’s protocol (BrdU Flow kit; BD) before analysis by flow cytometry.
The Fucci transgenic mouse model, in which cells in the S/
G2/M phase of the cell cycle were labeled with a green-emitting fluorescent protein, was also used to identify proliferating
cells through flow cytometry.
In vivo bead uptake
The ability of cells to uptake beads in vivo was assessed as
previously described (Tacke et al., 2007). In brief, 0.5 µm
Fluoresbrite polychromatic red microspheres (2.5% solids
CXCR4 in monocyte development and lung margination | Chong et al.
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Materials and methods
Mice and treatments
C57BL/6 mice (6–10-wk-old) were bred and maintained
under specific pathogen–free conditions in the Biological
Resource Centre (BRC) of A*STAR, Singapore. Lyz2cre/cre
Cx3cr1gfp/+
(B6.129P(B6.129P2-Lyz2tm1(cre)Ifo/J),
tm1Litt
fl/fl
Cx3cr1
/J), Cxcr4 (B6.129P2-Cxcr4tm2Yzo/J), NOD-scid
Il2rg−/− (NSG; NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ), Rosa26mT/mG
(STOCK Gt(ROSA)26Sortm4(ACTB-tdTomato,-EGFP)Luo/J), and CD45.1
mice were obtained from The Jackson Laboratory. Fucci-474
mice were from the Institute of Physical and Chemical Research
BioResource Center (Ibaraki, Japan; Sakaue-Sawano et al.,
2013). Lyz2cre/cre mice were crossbred in-house with Cxcr4fl/fl
mice to generate progeny that were CXCR4-deficient in
the myeloid lineage only (termed Lyz2creCxcr4fl; Eash et al.,
2009). Tlr4−/− mice were obtained from Oriental BioService.
Gain-of-function Cxcr41013/+ mice (termed Cxcr4WHIM) were
provided by F. Bachelerie (Balabanian et al., 2012). For fatemapping purposes, LyzcreCxcr4fl were crossed to Rosa26mT/mG
mice (termed RosamT/mG:LyzcreCxcr4fl). Humanized mice
were generated as described (Chen et al., 2013). All transgenic
mice were maintained on a C57BL/6 background and
experiments were performed under the approval of the
Institutional Animal Care and Use Committee (IACUC) of
the BRC, in accordance with the guidelines of the Agri-Food
and Veterinary Authority (AVA) and the National Advisory
Committee for Laboratory Animal Research (NAC
LAR)
of Singapore. Mice were treated with 5mg/kg AMD3100
(plerixafor; Sigma-Aldrich) via subcutaneous injection and/
or with 10 ng LPS derived from Escherichia coli (serotype
O55:B5; Alexis Biochemicals) administered via intravenous
route. All experiments were performed between ZT4 to ZT8
unless otherwise stated.

from eBioscience, BioLegend, BD, or R&D Systems. Mouse
cells were stained with the following antibodies: CCR2
(475301), CD3e (145-2C11), CD4 (GK1.5), CD8 (53–6.7),
CD11b (M1/70), CD11c (N418), CD16/32 (93), CD19
(eBio1D3), CD31 (390), CD34 (RAM34), CD43 (S7),
CD45 (30-F11), CD45.1 (A20), CD45.2 (104), CD45R/
B220 (RA3-6B2), CD49a (HMα1), CD49f (GoH3), CD62L
(MEL-14), CD71 (YTA74.4), CD88 (20/70), CD115
(AFS598), CD172a (P84), CD274 (10F.9G2), cKit (2B8),
CXCR4 (2B11), CX3CR1 (SA011F11), F4/80 (CI:A3-1),
Flt3 (A2F10), IA-IE (M5/114.152), Ly6C (HK1.4), Ly6G
(1A8), NK1.1 (PK136), and Ter119 (TER-119). Human
cells were stained with the following antibodies: CD3
LA), CD11b (ICRF44),
(UCHT1), CD10 (eBioCB-CAL
CD11c (B-ly6), CD14 (322A-1), CD16 (3G8), CD19
(HIB19), CD20 (2H7), CD34 (581), CD45 (HI30), CD56
(MEM188), CD123 (6H6), CXCR4 (12G5), and HLA-DR
(L243). Dead cells were identified and excluded using DAPI
staining. Lung, blood, and BM monocytes were identified as
CD45+CD115+cKit−Ly6G−Lineage (CD3, CD19, CD45R,
and NK1.1) negative and Ly6ChiCD43− or Ly6CloCD43+
according to the subset in mice and human BM classical
monocytes identified as CD14+CD16−CD11b+CD34−HLADR+Lineage− (CD3, CD10, CD19, CD20, CD56, and
CD123). Cells were acquired on a BD LSR II flow cytometer
(BD) using FACSDiva Software, and data were analyzed using
FlowJo Software (Tree Star). Total number of cells collected
from blood or each tissue/organ was quantified using count
beads (CountBright; Life Technologies) according to the
manufacturer’s protocol. CXCR4 expression on monocytes
was quantified as median fluorescent intensity (MFI) and
normalized by subtracting the fluorescence minus one (FMO)
control. For cell sorting, BM cells were sorted using a FAC
SAria II (BD) to achieve >98% purity.
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[wt/vol]; Polysciences Inc.) were diluted 1:25 in PBS, and
250 µl of the solution was injected into the lateral tail vein of
mice. After 4 h, mice were sacrificed and BM was collected,
flushed, and stained with antibodies to distinguish the different monocyte cell populations.

Dimensionality reduction using t-SNE
and automatic clustering
BM Ly6Chi monocytes were manually gated from multicolor
flow cytometry data. as shown in Fig. 1 A, and were exported
in a FCS file. In this study, t-Distributed Stochastic Neighbor
Embedding (t-SNE) dimensionality reduction was performed
using bh_tsne, an implementation of t-SNE via Barnes-Hut
approximations. R was used as an interface to execute bh_
tsne, as previously described (Becher et al., 2014). K-means
automatic clustering was performed using CYT in Matlab.
90,000 events were used for t-SNE dimensionality reduction.
Transcriptomics
cMoP, Ly6ChiCXCR4hi, Ly6ChiCXCR4lo, and Ly6Clo monocytes were sorted according to the gating strategy shown in
Fig. 2 A. After sorting, cells were incubated for 3 h in RPMI
+ 10% FCS and were then subjected to RNA isolation. Total
RNA was extracted using Arcturus PicoPure RNA Isolation kit according to the manufacturer's protocol. All mouse
RNAs were analyzed on Perkin Elmer Labchip GX system
for quality assessment with RIN > 7.9. cDNA libraries were
prepared using 2 ng of total RNA and 1 µl of a 1:50,000
dilution of ERCC RNA Spike in Controls (Ambion) using
SMARTSeq v2 protocol (Picelli et al., 2014), except for the
following modifications: (1) use of 20 µM TSO; and (2) use
of 250 pg of cDNA with 1/5 reaction of Illumina Nextera
XT kit. The length distribution of the cDNA libraries was
monitored using DNA High Sensitivity Reagent kit on the
Perkin Elmer Labchip. All eight samples were subjected to an
JEM Vol. 213, No. 11

Computational inference of developmental path
CMap (Lamb et al., 2006) analysis was performed using DEGs
between Ly6ChiCXCR4lo and Ly6Clo monocytes. Positive
CMap scores indicate enrichment of Ly6Clo signature genes,
whereas negative CMap scores indicate enrichment of Ly6Chi
signature genes. R package seriation (Hahsler et al., 2008) was
used to find a suitable linear order for cMoP, CXCR4hi, and
CXCR4lo Ly6Chi monocytes. Six different seriation methods,
including TSP, R2E, ARSA, HC, GW, and OLO, were applied.
TSP, ARSA, and OLO produced the best and identical results
with regard to the shortest path length, minimal AR events,
and minimum Moore stress. Seriation analysis was done using
log2CPM values of all detected genes. PCA, CMap, and seriation analyses suggest a developmental path from cMoP to
CXCR4hi, followed by CXCR4lo Ly6Chi monocyte.
Wanderlust was executed using CYT in Matlab, as
previously described (Bendall et al., 2014). Wanderlust was
run on six phenotypic markers: CXCR4, CD31, CD16/32,
CX3CR1, CCR2, and CD11b, using the following parameters: number of neighbors l = 30, k = 5, number of landmarks
nl = 20, number of graphs to generate ng = 25, distance metric = angular. The starting point (early events) consisted of
selected Ly6Chi cells that expressed high levels of CXCR4,
CD31, and CD16/32, as observed on cMoPs, which is the
most direct progenitor of BM Ly6Chi monocytes. 90,000
events were used for Wanderlust analysis.
Parabiosis and BM chimeric mice
Female mice were anesthetized using 2.5% Avertin (15 ml/
kg), shaved at the corresponding lateral sides of the body, and
then surgically joined as previously described (Hashimoto et
al., 2013). After surgery, the mice were treated with Baytril
(0.05–2 mg/kg s.c.) and Buprenorphine (5–20 mg/kg s.c.)
and allowed to recover for 8 wk. Since Lyz2creCxcr4fl and
Cxcr4WHIM mice exhibit steady-state monocytosis and monocytopenia, respectively, parabiosis with WT animals results in
unequal exchange of circulating leukocytes (Fig. 6 C); the re2309
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Adoptive transfer of BM monocytes
Femurs and tibias were harvested from CD45.1 mice and
flushed with ∼5 ml PBS containing 3% FCS. RBCs were
lysed and the remaining cells were resuspended in sterile PBS.
A total of 10 million CD45.1 donor cells were adoptively
transferred into CD45.2 recipient mice that were simultaneously treated with AMD3100 or PBS. Recipient mice
were euthanized at the time points indicated in the respective figures, and the perfused femurs were harvested for flow
cytometric identification of donor monocyte (CD45.1) sequestration into the BM of recipient animals (CD45.2).
For intrafemoral transfer of BM Ly6Chi monocyte subsets,
sorted 5 × 105 CD45.1+ CXCR4hi were suspended in PBS
and were transferred into the left femur of CD45.2+ mice
via an insulin syringe with a short needle (BD). At 8 and
24 h after cell transfer, BM femurs were collected, and the
resulting cell suspensions were analyzed by flow cytometry
to establish the phenotype of the CD45.1+ progeny of the
transferred cell populations.

indexed PE sequencing run of 2 × 51 cycles on an Illumina
HiSeq 2500 Rapid mode (14 samples/lane).
RNA-Seq data in the form of FASTQ files were subsequently mapped to the mouse genome build mm10 using
the STAR alignment software. The mapped reads were then
counted using featureCounts (part of Subread package) based
on the GENCODE M9 annotations. The raw counts were
then used for a differential gene expression analysis (DEG)
using edgeR (R version 3.1.2) with adjusted P < 0.05 and
fold change >2 to identify genes differentially regulated in
monocyte subsets. A filter for genes having a mean count of
at least 10 was done to eliminate low expressing and nonexpressing genes before DEG analysis. PCA of samples was
done using log2CPM (count per million reads) values of
all detected genes. PCA, volcano plot, and heat maps were
done in R version 3.1.2. Pathway analysis of DEGs was done
using IPA software (Qiagen).
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sults of these experiments were hence represented as a homing
ratio to control for differences in absolute cell numbers between these mice. To determine the number of cells that had
infiltrated a given organ, the number of nonhost cells present
in that organ was divided by the total number of nonhost cells
present in the host circulation (expressed as the homing ratio).
To determine the total number of circulating cells, the blood
volume present in an individual mouse was calculated using
the formula: y = 0.0715 x, where y and x represent the blood
volume (milliliters) and body weight (grams), respectively, as
previously described (van Furth and Sluiter, 1986).
To generate BM chimeric mice, 6-wk-old WT and
Tlr4−/− mice were irradiated with two doses of 550 rad
spaced 3 h apart and reconstituted with BM from WT or
Tlr4−/− mice under sterile conditions. Recipient mice were
analyzed 6 wk after irradiation, and number of Ly6Chi monocytes were quantified 1 h after administration of LPS.

Intravital multiphoton imaging of lung
Imaging of the lung was performed as previously described
(Looney et al., 2011). In brief, mice were anaesthetized with
a cocktail of ketamine and xylazine before cannulation of
the trachea to allow connection to a mechanical ventilator
(tidal volume, ∼8–10 µl/g body weight; respiratory rate, ∼120
breaths per minute; MiniVent 845; Hugo Sachs Elektronik).
Mice were then placed onto a heat pad to maintain body
temperature at 37°C, followed by the removal of skin, muscle, and two rib bones to expose the lung. A custom-made
vacuum window ring was used to immobilize the lung via
application of a negative pressure vacuum (∼40 mmHg). To
label the pulmonary vasculature, 70kD TRITC-conjugated
dextran (250 µg in 100 µl saline; Sigma-Aldrich) or Evan’s
blue (50 µg in 50 µl sterile PBS) was administered i.v. into
mice. Experimental groups consisted of mice administered
with AMD3100 s.c., LPS i.v., or a combination of AMD3100
and LPS administered together via the different routes. Imaging of the lung began 45 min after single treatment with
AMD3100 or LPS, whereas co-treatment of both AMD3100
and LPS were imaged at 2 h into AMD3100 and 45 min
into LPS simultaneously. For the visualization of monocyte
subsets, 4 µg of Ly6B.2-PE (Novus Biologicals) were admin2310

Localization of intravascular lung monocytes
Intravascular staining of lung monocytes was performed in
vivo according to a previously described protocol (Anderson et al., 2014). In brief, mice were anaesthetized by isoflurane inhalation and APC-conjugated anti-CD45.2 (clone
104; eBioscience) was administered i.v. (4 µg antibody in
200 µl saline). The antibody was allowed to circulate for 3
min before the mice were euthanized. Lungs were removed
en bloc and processed immediately in an excess volume of
PBS containing 3% FCS and 2 mM EDTA to dilute any
excess antibody. FITC-conjugated anti-CD45.2 (clone 104;
eBioscience) was included in the antibody-staining panel to
identify extravascular cells.
Lung efflux assay
The method used for tandem blood sample collection from
the carotid artery and vena cava has been described previously
(Devi et al., 2013). In brief, mice were anesthetized with isoflurane and a midline incision was performed on the neck to
expose the underlying carotid artery. A microvascular clamp
was applied to the artery, which was then cannulated by insertion of EDTA-filled polyethylene 10 tubing (inner diam, 0.28
mm; outer diam, 0.61 mm). After securing the cannula with
a surgical suture, the clamp was released and ∼40 µl of arterial blood was collected into an Eppendorf tube. Blood was
simultaneously drawn from the inferior vena cava using a 26gauge needle attached to a prefilled EDTA syringe. Samples
were collected 1 h after LPS injection, or 2 h after AMD3100
treatment. For mice that were cotreated with AMD3100 and
LPS, the CXCR4 inhibitor was administered 1 h before injection of LPS, and blood sample collection took place an
additional 1 h later. Both arterial and venous blood samples
were subsequently analyzed by flow cytometry.
For lung efflux assays done on nonhuman primates, all
experiments were performed on adult female Macaca fascicularis at the Singhealth Experimental Medicine Center
(accredited by the Association for Assesment and Accrediation
of Laboratory Animal Care) under approval #2012/SHS/692
from the Institutional Animal Care and Use Committee of
Singapore, as previously described (Devi et al., 2013). In brief,
midline laparotomy was performed under general anesthesia
and ∼1 ml of blood was each collected from the abdominal
CXCR4 in monocyte development and lung margination | Chong et al.
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Scanning electron microscopy
Sorted CXCR4hi and CXCR4lo monocytes were seeded
onto coverslips and incubated at 37°C, 5% CO2, for 3 h to
allow cell adhesion onto coverslips. Cells were fixed with
2.5% Glutaraldehyde (Sigma-Aldrich) in PBS, washed, and
post-fixed in 1% Osmium tetroxide (Electron Microscopy
Services) in PBS, and then dehydrated in ethanol and processed by critical point drying (EM CPD030; Leica). Finally,
samples were sputter-coated with gold using an EM SCD050
(Leica) and imaged on the JSM-6701F, JEOL scanning electron microscope at 4,000 × magnification. 60–70 cells were
acquired for each tested group and representative images of a
typical phenotype were presented in the figure.

istered i.v. in Cx3cr1gfp/+ mice (Fig. 8, E and F). Experiments
were performed at 880 or 990 nm excitation and 364 × 364
µm images were acquired in fast mode over a period of 30
min using a 4-µm z-step size with an approximate depth of 20
µm. After acquisition, images were averaged to match respiratory movements, and drifts during imaging were corrected
where necessary (FIJI software). Images were subsequently
transformed into time series movies using Imaris. Tracking
of GFP+ cells was performed semiautomatically using Imaris
spot-tracking algorithms, and mean velocity was extracted.
The duration of GFP+ cell adherence in the lung vasculature
was tabulated manually.
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aorta and inferior vena cava at baseline and hourly intervals
after s.c. administration of AMD3100 (0.5 mg/kg). Monocyte numbers were determined using a Hematology Analyzer (Beckman-Coulter).
The number of monocytes leaving the pulmonary
circulation (termed net release) was calculated by subtracting the number of monocytes present in the venous
blood sample from the number of monocytes present in
the arterial blood sample.

Chemotaxis assay
Femurs and tibias were harvested from C57BL/6 mice and
flushed with ∼5 ml of PBS containing 3% FCS. RBCs were
lysed and the resultant cells were suspended in sterile PBS
for labeling with antibodies against CD11b, CD45, CD115,
CXCR4, Flt3, cKit, and Ly6C, as well as an exclusion cocktail of antibodies against unwanted lineages (CD3, CD45R/
B220, Ly6G, and NK1.1). BM monocytes were identified as
Lin−Flt3−cKit−CD115+Ly6Chi cells that displayed either a
CXCR4hi or CXCR4lo phenotype. The CXCR4hi and CXCR4lo subsets were then sorted at high speed using a BD
FACSAria III apparatus (BD). A total of 105 sorted monocytes
were transferred onto the top layer of a polycarbonate membrane with 3 µm pore size (Transwell; Corning), before being
placed into lower chambers containing 0–50 ng of recombinant CCL2 (R&D Systems) and incubated at 37°C for 2 h.
After incubation, the cells in the bottom chamber were harvested and analyzed by flow cytometry to determine the percentage of migrated monocytes (expressed as a proportion of
the total cells that were initially loaded into the top chamber).
CLP-induced sepsis
Experimental procedures were performed as previously described (Rittirsch et al., 2009). In brief, the peritoneal cavity was exposed under ketamine/xylazine anesthesia and the
JEM Vol. 213, No. 11

Statistical analysis
Statistical analyses were performed using Prism software
(GraphPad). Data were tested using either Student’s t test
(normal distribution) or ANOVA (one-way or two-way as
appropriate), as indicated in the respective figure legends. P <
0.05 was considered significant.
Accession nos.
All RNA-sequencing data have been deposited at the National Center for Biotechnology Information Gene Expression Omnibus public database under accession no. GSE86079.
Online supplemental material
Fig. S1 shows heat maps of genes that are significantly and
differentially expressed between cell subsets of the monocyte
developmental pathway. Fig. S2 shows detailed histograms
of cell surface marker expression for distinguishing monocyte subsets. Fig. S3 shows gating strategy for the analysis of
CXCR4 expression on BM Ly6Chi monocytes. Fig. S4 shows
gating strategy of blood monocytes in mice. Video 1 shows
monocyte margination in the pulmonary vasculature.Video 2
shows the visualization of Ly6Chi monocytes in a Cx3cr1gfp/+
mouse with an anti-Ly6B.2 antibody.
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Figure S1. Heatmaps of genes between cell subsets of the monocyte developmental pathway. (A–G) NGS was performed on RNA extracted from
sorted BM cMoPs, CXCR4hi and CXCR4lo Ly6Chi monocytes and Ly6Clo monocytes from three individual mice. Heat maps showing genes that are involved
in cell cycle (A), DNA metabolic processes (B), cell activation and antigen presentation (C), phagocytosis (D), cell motility and adhesion (E), chemokines and
inflammation (F) and development and differentiation (G).
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Figure S2. Cell surface marker expression for distinguishing monocyte subsets. Flow cytometry was performed on BM cMoPs, CXCR4hi and CXCR4lo
Ly6Chi monocytes and Ly6Clo monocytes for the analysis of indicated surface markers. Results are representative of one out of two independent experiments.

Figure S3. Gating strategy for the analysis of CXCR4 expression on BM Ly6Chi monocytes. Representative flow cytometry plots showing progressive
BrdU incorporation into BM Ly6Chi monocytes (top panels) and subsequent gating for CXCR4 expression (bottom panels) of BrdU+ cells (red box), BrdU− cells
(blue box; n = 4–5 mice per group). Results representative of one out of two independent experiments.
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Figure S4. Gating strategy of blood monocytes in mice. Gating strategy for blood monocytes (pregated on DAPIneg/singlets). Monocytes are defined as
Lin(CD3/B220/NK1.1)−CD115+Ly6G−CD11b+ and Ly6ChiCD43− or Ly6CloCD43+ according to the subset. Flow cytometry plots are representative of one out of
at least three independent experiments.

Video 1. Monocyte margination in the pulmonary vasculature. Time-lapse image sequence of maximum intensity projection
displaying the behavior of GFP+ cells in the lungs (alveolar space) of Cx3cr1gfp/+ mice. TRITC-dextran (250 µg) was administered i.v.
to delineate the lung vasculature. Shown are the motility patterns of GFP+ monocytes at baseline and after treatment with LPS (10
ng), AMD3100 (5 mg/kg), or LPS and AMD3100 together. For mice treated with LPS, monocytes are observed to reduce their speed
and increase duration of adherence in the lung endothelium. This phenomenon was abolished when mice were pretreated with
AMD3100. Videos are representative of 3 mice per treatment. Elapsed time is shown as hours:minutes:seconds. Scale bar: 50 µm.

Video 2. Visualization of Ly6Chi monocytes in Cx3cr1gfp/+ mice with an anti-Ly6B.2 antibody. Time-lapse image sequence
of maximum intensity projection displaying the behavior of GFP+ cells in the lungs (alveolar space) of Cx3cr1gfp/+ mice. Evans blue
(50 µg) was administered i.v. to delineate the lung vasculature. 5 min after the beginning of imaging, Ly6B.2-PE (4 µg) was injected
i.v., and allowed the visualization of Ly6Chi monocytes (Ly6B.2+CX3CR1+), Ly6Clo monocytes (Ly6B.2−CX3CR1+) and neutrophils
(Ly6B.2+CX3CR1−). Video is representative of 3 mice. Elapsed time is shown as hours:minutes:seconds. Scale bar: 40 µm.
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